ly-2157299 has been researched along with lenvatinib* in 1 studies
1 other study(ies) available for ly-2157299 and lenvatinib
| Article | Year |
|---|---|
A novel immunosuppression-based classification of liver tumors opens new perspectives for adapted therapeutic strategies.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; B7-H1 Antigen; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Immunotherapy, Adoptive; Liver Neoplasms; Phenylurea Compounds; Programmed Cell Death 1 Receptor; Pyrazoles; Quinolines; Sunitinib; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Tumor-Associated Macrophages | 2020 |